08/21/2026
Recent advances in EU trial regulation now “requires that the people enrolled in trials reflect the populations likely to use a medicine.” This initiative aims to expand gender representation, accurately portray demographics & improve women’s healthcare.
Agency will review trial enrollment in public database to ensure studies reflect populations likely to use approved medicines